Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $961,904 | 478 | 67.0% |
| Consulting Fee | $218,853 | 86 | 15.3% |
| Travel and Lodging | $111,680 | 218 | 7.8% |
| Honoraria | $88,960 | 18 | 6.2% |
| Food and Beverage | $38,510 | 970 | 2.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $10,000 | 4 | 0.7% |
| Long term medical supply or device loan | $4,875 | 1 | 0.3% |
| Education | $14.92 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $744,152 | 673 | $0 (2024) |
| W. L. Gore & Associates, Inc. | $156,338 | 146 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $149,440 | 197 | $0 (2024) |
| Amgen Inc. | $130,765 | 173 | $0 (2024) |
| Inari Medical, Inc. | $73,448 | 51 | $0 (2024) |
| Esperion Therapeutics, Inc. | $42,937 | 34 | $0 (2024) |
| Abbott Laboratories | $39,428 | 32 | $0 (2024) |
| Cardiovascular Systems Inc. | $17,049 | 22 | $0 (2019) |
| The Spectranetics Corporation | $13,607 | 6 | $0 (2017) |
| PORTOLA PHARMACEUTICALS, INC. | $12,549 | 14 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $106,799 | 158 | Janssen Pharmaceuticals, Inc ($51,846) |
| 2023 | $128,730 | 136 | Janssen Pharmaceuticals, Inc ($50,703) |
| 2022 | $233,636 | 226 | Janssen Pharmaceuticals, Inc ($152,343) |
| 2021 | $182,807 | 231 | Janssen Pharmaceuticals, Inc ($125,818) |
| 2020 | $129,902 | 161 | Janssen Pharmaceuticals, Inc ($69,938) |
| 2019 | $215,385 | 278 | Janssen Pharmaceuticals, Inc ($136,508) |
| 2018 | $228,102 | 306 | Janssen Pharmaceuticals, Inc ($92,539) |
| 2017 | $209,437 | 281 | Novartis Pharmaceuticals Corporation ($87,337) |
All Payment Transactions
1,777 individual payment records from CMS Open Payments — Page 1 of 72
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | AngioDynamics, Inc. | Auryon Laser System 100-120 Vac (Device) | Long term medical supply or device loan | In-kind items and services | $4,875.00 | General |
| Category: ET | ||||||
| 12/30/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Lithoplasty | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $128.67 | General |
| Category: Cardiovascular | ||||||
| 12/12/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $56.85 | General |
| Category: Lithoplasty | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Consulting Fee | Cash or cash equivalent | $4,020.00 | General |
| Category: Devices | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device), GORE VIABAHN Endoprosthesis | Consulting Fee | Cash or cash equivalent | $2,010.00 | General |
| Category: Devices | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Consulting Fee | Cash or cash equivalent | $1,340.00 | General |
| Category: Devices | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Consulting Fee | Cash or cash equivalent | $670.00 | General |
| Category: Devices | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Food and Beverage | In-kind items and services | $166.97 | General |
| Category: Devices | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Travel and Lodging | In-kind items and services | $144.10 | General |
| Category: Devices | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Travel and Lodging | In-kind items and services | $53.92 | General |
| Category: Devices | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Food and Beverage | In-kind items and services | $40.68 | General |
| Category: Devices | ||||||
| 11/08/2024 | Smith+Nephew, Inc. | STRAVIX MESH (Medical Supply) | Food and Beverage | In-kind items and services | $38.03 | General |
| Category: Extra Cellular Matrix | ||||||
| 11/07/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: VTE | ||||||
| 11/03/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Travel and Lodging | In-kind items and services | $518.71 | General |
| Category: Devices | ||||||
| 11/01/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Travel and Lodging | In-kind items and services | $344.67 | General |
| Category: Devices | ||||||
| 10/31/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN Endoprosthesis with Heparin (Device) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Devices | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN Endoprosthesis with Heparin (Device) | Travel and Lodging | In-kind items and services | $774.80 | General |
| Category: Devices | ||||||
| 10/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,042.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/24/2024 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $43.43 | General |
| Category: Stents | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN Endoprosthesis (Device) | Consulting Fee | Cash or cash equivalent | $4,355.00 | General |
| Category: Devices | ||||||
| 10/04/2024 | CORDIS US CORP. | Mynx Venous VCD (Device) | Food and Beverage | In-kind items and services | $39.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/04/2024 | Bracco Diagnostics Inc. | Lumason (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Diagnostic Imaging | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,435 | 1,600 | $597,907 | $99,806 |
| 2022 | 25 | 1,139 | 1,224 | $298,339 | $59,356 |
| 2021 | 24 | 926 | 1,024 | $488,425 | $116,253 |
| 2020 | 26 | 901 | 1,004 | $539,265 | $100,622 |
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 45 | 53 | $150,066 | $23,188 | 15.5% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 109 | 110 | $125,902 | $17,555 | 13.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 270 | 271 | $77,749 | $14,049 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 85 | 101 | $24,178 | $6,972 | 28.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 26 | 26 | $37,112 | $5,536 | 14.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 86 | $23,760 | $5,416 | 22.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 72 | 73 | $26,146 | $4,256 | 16.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 33 | $17,292 | $3,452 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 31 | 31 | $11,018 | $3,003 | 27.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 75 | 119 | $18,353 | $2,637 | 14.4% |
| 93455 | Insertion of tube in bypass graft for diagnosis with review by radiologist | Facility | 2023 | 11 | 11 | $14,717 | $1,892 | 12.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 93 | 95 | $8,043 | $1,537 | 19.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 32 | 52 | $16,040 | $1,389 | 8.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 20 | 20 | $4,940 | $1,325 | 26.8% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Facility | 2023 | 79 | 83 | $4,075 | $1,302 | 32.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 106 | 109 | $6,150 | $1,097 | 17.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 95 | 96 | $5,422 | $1,010 | 18.6% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 12 | 12 | $5,468 | $913.32 | 16.7% |
| 78451 | Nuclear medicine study of heart muscle at rest and with stress and spect | Facility | 2023 | 13 | 13 | $3,961 | $656.89 | 16.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 16 | $2,400 | $637.28 | 26.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 33 | 33 | $4,368 | $606.05 | 13.9% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Facility | 2023 | 18 | 20 | $4,106 | $563.67 | 13.7% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 28 | 28 | $3,332 | $335.43 | 10.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 27 | 37 | $1,221 | $213.17 | 17.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 33 | 33 | $993.00 | $175.46 | 17.7% |
About Dr. Matthew Becker, MD
Dr. Matthew Becker, MD is a Cardiovascular Disease healthcare provider based in Erie, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1598932550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Becker, MD has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $106,799 received in 2024. These payments were reported across 1,777 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($961,904).
As a Medicare-enrolled provider, Becker has provided services to 4,401 Medicare beneficiaries, totaling 4,852 services with total Medicare billing of $376,036. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Erie, PA
- Active Since 05/09/2008
- Last Updated 09/21/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1598932550
Products in Payments
- XARELTO (Drug) $744,315
- ENTRESTO (Drug) $149,426
- Repatha (Biological) $130,577
- CT THROMBECTOMY SYSTEM KIT (Device) $58,915
- NEXLIZET (Drug) $40,523
- VIABAHN Endoprosthesis (Device) $38,096
- VIABAHN VBX Balloon Expandable Endoprosthesis (Device) $28,041
- GORE VIABAHN VBX Balloon Expandable Endo (Device) $24,486
- GORE VIABAHN Endoprosthesis (Device) $21,810
- Omnilink Elite vascular stent system (Device) $21,150
- Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter (Device) $17,689
- Peripheral Orbital Atherectomy System (Device) $16,944
- FLOWTRIEVER CATHETER, S (Device) $14,533
- CVX-300CVX-300P (Device) $13,600
- BEVYXXA (Drug) $12,549
- CAMZYOS (Drug) $11,590
- CARDIOFORM Septal Occluder (Device) $11,503
- GORE CARDIOFORM Septal Occluder (Device) $9,077
- Product in Development (Device) $9,039
- DyeVert (Device) $8,434
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Erie
Dr. Nishant Koradia, M.d, M.D
Cardiovascular Disease — Payments: $21,487
Dr. Jonathon Wertz, M.d, M.D
Cardiovascular Disease — Payments: $15,214
Mohamad Khaled Sabeh, M.d, M.D
Cardiovascular Disease — Payments: $11,498
Kevin Mikielski, Do, DO
Cardiovascular Disease — Payments: $6,744
Dr. Mark Izzo, Md, MD
Cardiovascular Disease — Payments: $6,354
Mr. Farhad Sami, M.b.b.s, M.B.B.S
Cardiovascular Disease — Payments: $5,152